Recurrent Miscarriage Treatment

Unfortunately, not every pregnancy concludes with a live birth. Roughly estimated, one in every five pregnancies results in a miscarriage. Specifically, individuals who experience two consecutive miscarriages are considered to have recurrent miscarriage. In these patients, various tests such as genetic analysis, Lupus anticoagulant, anti-cardiolipin antibodies, blood tests for thyroid hormones and prolactin, and examinations like saline ultrasound or hysteroscopy are performed to investigate the uterine environment. However, in 75% of patients, no specific cause can be identified. In cases of recurrent miscarriage without a known cause, it is often presumed that the fertilized egg is genetically flawed.

Normally, the uterus does not accept a defective egg, preventing the establishment of pregnancy. However, in patients with recurrent miscarriages, the latest hypothesis suggests that, despite poor embryo quality or genetic abnormalities, the uterus allows pregnancy to occur but later halts development, resulting in miscarriage. To prevent this, we offer our patients a new treatment option. We select and transfer the healthiest embryo to prevent miscarriages. Embryos undergo a genetic test called NGS, which examines all 46 chromosomes present in human cells. Following this test, the genetically flawless embryo with the most optimal development is placed into the prospective mother's uterus. Thanks to this new treatment option, the majority of patients with recurrent miscarriages are now able to welcome healthy babies into their lives.